Clinical trialNCT06975293RecruitingPhase 1/PHASE2Interventional

STC-15 as a Part of Combination Therapy With Toripalimab in Selected Advanced Cancers and as Monotherapy in Participants With Selected Sarcomas

SponsorSTORM Therapeutics LTDEnrollment107Dedifferentiated LiposarcomaLeiomyosarcomaSarcomaSolid Tumor

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Sandra Tong, MD
Storm Therapeutics
Study Director
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Northwell Health Cancer Institute
Lake Success, New York, United States
Anthony Philip, MD
Recruiting
Next Houston
Houston, Texas, United States
Jennifer Segar, MD
Recruiting
Next Dallas
Irving, Texas, United States
Faran Polani, MD
Recruiting
Next Oncology
San Antonio, Texas, United States
Ildefonso I Rodriguez Rivera, MD
Recruiting
the Start Center
San Antonio, Texas, United States
Kyriakos Papadopoulos, MD
Recruiting
Next Oncology
Fairfax, Virginia, United States
M. Adham Salkeni, MD, FRCPC
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 5 May 2025
Primary completion: 29 Dec 2027
Completion: 29 Jun 2028
Last update posted: 21 Apr 2026
Registered enrollment: 107
Registry id: NCT06975293

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.